The U.S. district attorney for Massachusetts filed suit against the drugmaker last week, alleging that it paid tens of millions in kickbacks through a copay foundation for Eylea, a drug used to treat macular degeneration.

Source: http://feedproxy.google.com/~r/abovethelaw/~3/Hq7CRTNlZY4/